OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients.
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 07 Dec 2015 New trial record